U.S. patent application number 16/866327 was filed with the patent office on 2020-08-27 for neurostimulators and stimulation systems.
This patent application is currently assigned to THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH. The applicant listed for this patent is THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH. Invention is credited to Brian R. Dearden, Edward K. F. Lee, Harshit Suri.
Application Number | 20200269054 16/866327 |
Document ID | / |
Family ID | 1000004824542 |
Filed Date | 2020-08-27 |
United States Patent
Application |
20200269054 |
Kind Code |
A1 |
Dearden; Brian R. ; et
al. |
August 27, 2020 |
NEUROSTIMULATORS AND STIMULATION SYSTEMS
Abstract
In accordance with the present invention, various embodiments of
neurostimulators and stimulation systems are disclosed that provide
different shapes and patterns of stimulus pulses and trains of
pulses with fixed and no fixed frequencies. The neurostimulator can
be configured to provide high frequency stimulation and also be
implantable in the head or neck regions in order to stimulate
nerves and nerve ganglions in the head and neck regions and also
stimulate the brain.
Inventors: |
Dearden; Brian R.;
(Pasadena, CA) ; Suri; Harshit; (Pasadena, CA)
; Lee; Edward K. F.; (Fullerton, CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH |
Valencia |
CA |
US |
|
|
Assignee: |
THE ALFRED E. MANN FOUNDATION FOR
SCIENTIFIC RESEARCH
Valencia
CA
|
Family ID: |
1000004824542 |
Appl. No.: |
16/866327 |
Filed: |
May 4, 2020 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15851646 |
Dec 21, 2017 |
10639480 |
|
|
16866327 |
|
|
|
|
62438023 |
Dec 22, 2016 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61N 1/36067 20130101;
A61N 1/37235 20130101; A61N 1/36196 20130101; A61N 1/36178
20130101; A61N 1/025 20130101; A61N 1/36171 20130101; A61N 1/0556
20130101; A61N 1/0534 20130101; A61N 1/37223 20130101; A61N 1/0553
20130101; A61N 1/0504 20130101; A61N 1/36075 20130101 |
International
Class: |
A61N 1/36 20060101
A61N001/36; A61N 1/02 20060101 A61N001/02; A61N 1/05 20060101
A61N001/05; A61N 1/372 20060101 A61N001/372 |
Claims
1. An implantable neurostimulator for deep brain stimulation, the
neurostimulator, comprising: a housing that is sized and shaped for
implantation in the head or neck; and a lead connector configured
to connect to a stimulation lead having one or more electrode
contacts, which contacts are implanted in the brain, wherein the
neurostimulator is capable of providing to the brain, a selectable
stimulus frequency in at least the range from about 100 Hz to about
4.8 KHz.
2. The system of claim 1, wherein the neurostimulator is capable of
providing a selectable stimulus frequency in at least the range
from about 500 to about 4.8 kHz.
3. The system of claim 1, wherein the neurostimulator is capable of
providing a selectable stimulus frequency in at least the range
from about 100 Hz to about 1 kHz.
4. The system of claim 1, wherein the neurostimulator is capable of
providing a selectable stimulus frequency in at least the range
from about 100 Hz to about 500 Hz.
5. A method for implementing deep brain stimulation comprising:
providing an implantable neurostimulator, wherein the
neurostimulator is capable of providing a selectable stimulus
frequency in at least the range from about 100 Hz to about 4.8 KHz;
providing at least one stimulation lead that can be connected to
the neurostimulator, the lead having one or more electrode
contacts; and implanting into the brain the part of the lead having
the one or more electrode contacts.
6. The method of claim 5, wherein the neurostimulator is capable of
providing a selectable stimulus frequency in at least the range
from about 500 to about 4.8 kHz.
7. The method of claim 5, wherein the neurostimulator is capable of
providing a selectable stimulus frequency in at least the range
from about 100 Hz to about 1 kHz.
8. The method of claim 5, wherein the neurostimulator is capable of
providing a selectable stimulus frequency in at least the range
from about 100 Hz to about 500 Hz.
Description
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of U.S. Nonprovisional
application Ser. No. 15/851,646 filed on Dec. 21, 2017, which
claims the benefit of U.S. Provisional Application No. 62/438,023,
filed Dec. 22, 2016, both of which are incorporated by
reference.
FIELD OF THE INVENTION
[0002] The present invention relates to implantable
neurostimulators, electrode leads, stimulation systems and methods
of use and, more particularly, relates to stimulation of nerve
targets in the head (including facial and chin) and neck areas to
treat various ailments, including headache, migraine, and facial
pain. In addition, the present invention relates to implantable
neurostimulators and systems for use in deep brain stimulation to
treat such conditions as Parkinson's disease and essential
tremor.
BACKGROUND OF THE INVENTION
[0003] Most neurostimulators on the market were originally
developed for stimulation of nerves in the spinal cord to treat
chronic pain. In most cases the neurostimulators were not intended
for stimulation of nerves in the neck and face. The
neurostimulators can be relatively large, since they were designed
to be placed in the body such as the torso and chest areas. Because
of their relatively large size, when these neurostimulators have
been adapted for use (off-label) by physicians to stimulate nerves
in the neck or head area, they have been implanted in the chest,
torso, or back of the patient and not in the head.
[0004] In addition, the typical neurostimulators that have been
available deliver electrical stimulation that is a train of pulses
with selected, fixed parameters such as pulsewidths, amplitudes,
and stimulus frequency. Stimulus pulse amplitudes are generally a
constant voltage or a constant current amplitude, but not both.
Whether the neurostimulator provides constant voltage stimulus or
constant current stimulus is based on the design of the
neurostimulator. These typical stimulation choices are limiting and
are not optimal for every treatment use.
[0005] Headache, migraine, and facial pain disorders are a
substantial health concern that can have a negative impact on
social activities and work. In some instances, it can lead to over
consumption of pain relieving drugs. There has been some clinical
work to use neurostimulators that have been designed for spinal
cord stimulation to treat headache and migraine. The
neurostimulator is implanted subcutaneously (under the skin) either
in the chest or back area of a patient and a stimulation lead or
leads, connected to the neurostimulator, are tunneled underneath
the skin, up the neck, and to a target nerve such as the occipital
nerve. Stimulation (usually a train of electrical stimulus pulses
at a fixed frequency) is delivered from the neurostimulator and via
electrode contacts located at the distal end of the stimulation
lead or leads to stimulate the target occipital nerve in order to
alleviate migraine or headache.
[0006] There are some drawbacks with these existing adapted
neurostimulator systems. The spinal cord neurostimulators are
relatively bulky and were never intended to be implanted in the
head, so they must be implanted in the back, torso or chest of a
patient. The leads must be tunneled through the neck into the head.
Since there is a great deal of movement in the neck, there will be
twisting action that causes the stimulation lead to move. It is
desirable to minimize lead movement once the lead is implanted.
[0007] In addition, it has been found that the conventional, fixed
stimulation frequencies, e.g., 35 Hz, offered by these
neurostimulators, while adequate for conventional spinal cord
stimulation, do not always provide relief from migraines or
headaches. Unlike the mechanism of chronic pain that is treated
with spinal cord stimulation, headaches and migraines are believed
to arise from many different causes and, hence, the present
inventors have surmised that a neurostimulator that can offer a
wider variety of stimulation other than a fixed 35 Hz stimulation
would have a greater chance to successfully treat more incidences
of headaches and migraines.
[0008] Neurostimulators and stimulation leads used in spinal cord
stimulation have also been adapted for use in deep brain
stimulation ("DBS"). Deep brain stimulation is currently being used
to treat movement disorders such as Parkinson's disease and
essential tremor. A lead extension may be used to connect the
neurostimulator to the stimulation lead. The lead extension or the
stimulation lead is tunneled subcutaneously through the neck and to
the top of the head, through a hole at the top of the skull, and
into the brain. Again, the drawbacks are that the neurostimulator
has to be placed in the chest, torso or back and not in the head.
The stimulation lead or lead extension must be tunneled through the
neck which subjects the lead or lead extension to unwanted
movement.
[0009] Nevro Corporation provides a neurostimulator in their
HF10.TM. system that is approved and marketed purely for spinal
cord stimulation and which offers selectable stimulus frequencies
up to 10 kHz. Stimulus amplitudes and pulsewidths, as well as
frequencies appear to be fixed, once selected and programmed. The
Nevro neurostimulator is sized and shaped to be placed generally in
the torso back, side or front chest area, and is specifically
designed to stimulate the spinal cord with multiple stimulation
channels. The Nevro neurostimulator is not intended to be implanted
in the head since it is too large and bulky. Although the Nevro
neurostimulator offers higher frequency stimulation than
conventional spinal cord stimulators, the Nevro device cannot be
implanted in the head. In addition, there is no known use of a
Nevro neurostimulator for stimulating nerves in the head or neck or
stimulating the brain for DBS application.
[0010] It would be desirable to have neurostimulators and
stimulation systems that can provide a wider choice of stimulation
patterns to stimulate various nerves in the body, and in particular
nerves and ganglions in the head, face and neck and also for DBS
applications.
SUMMARY OF THE INVENTION
[0011] The present invention address the above and other needs by
providing a neurostimulator and stimulation systems that can be
implanted in the head to stimulate nerves and nerve ganglions in
the head and neck and also to stimulate the brain. As referred to
herein in this disclosure, the word "head" will be used inclusively
to include the face, chin, under the chin, as well as the back, top
and sides of the head. Embodiments of the inventive neurostimulator
and stimulation system can be used for deep brain stimulation.
[0012] In one embodiment, in accordance with the invention, a
stimulation system is provided comprising: an implantable
neurostimulator having a housing that is sized and shaped to be
implanted subcutaneously in the head area; and at least one lead
connected to the neurostimulator, the lead having one or more
electrode contacts, wherein the neurostimulator is configured to
provide a train of stimulus pulses having a frequency in the range
covering at least 20 Hz to 4.8 kHz.
[0013] In another embodiment, in accordance with the invention, an
implantable stimulation system is provided comprising: a
neurostimulator having a housing that is sized and shaped to be
implanted in the head or neck; and at least one stimulation lead
that can be connected to the neurostimulator, the lead having one
or more electrode contacts, wherein the neurostimulator is capable
of providing a selectable stimulus frequency in at least the range
from about 100 Hz to about 4.8 kHz.
[0014] The neurostimulator can be capable of providing a selectable
stimulus frequency in at least the range from about 500 Hz to about
4.8 kHz. For clarity of meaning as used in this disclosure, a
neurostimulator having a programmable frequency range of 50 Hz to
5.0 kHz would meet the frequency range requirement "in at least the
range from about 500 Hz to about 4.8 kHz," since the latter range
is entirely covered by the first stated range. In other
embodiments, a neurostimulator can be capable of providing a
selectable stimulus frequency in at least the range from about 500
Hz to about 4.8 kHz; in at least the range of about 100 Hz to about
4.8 kHz; and in other embodiments, in at least the range of about
100 Hz to about 500 Hz. In all the above embodiments mentioned, the
stimulation lead may be configured to stimulate, among other nerves
in the head and neck, the occipital nerve, its branches, the
trigeminal nerve or its branches. In all the above embodiments, the
stimulation leads may have at the distal ends paddle-type electrode
leads, cuff-type electrode leads or linear-type (percutaneous)
electrode leads.
[0015] The implantable stimulation system can also include external
(not implanted) system components such as a patient programmer
and/or a clinician programmer which can be used to communicate,
program, and query the implanted neurostimulator.
[0016] In another embodiment, in accordance with the invention, a
neurostimulator is provided comprising: at least one lead connector
for connecting at least one stimulation lead having one or more
electrode contacts, wherein the neurostimulator is configured and
capable of providing stimulation with a pulse electrical stimulus
frequency at least in the range of about 20 Hz to 4.8 kHz. In some
embodiments, the neurostimulator has a housing that is sized and
shaped to be implanted subcutaneously over the skull.
[0017] In another embodiment, in accordance with the invention, a
neurostimulator is provided comprising: a housing that is sized and
shaped to be implanted subcutaneously over the skull; and at least
one lead connector for connecting at least one stimulation lead
having one or more electrode contacts, wherein the neurostimulator
is capable of providing stimulation with a pulse electrical
stimulus frequency in at least the range from about 100 Hz to about
4.8 kHz. In some embodiments, a neurostimulator can be capable of
providing a selectable stimulus frequency in at least the range
from about 500 Hz to about 4.8 kHz; in at least the range of about
100 Hz to about 4.8 kHz; and in at least the range of about 100 Hz
to about 500 Hz.
[0018] In another embodiment, in accordance with the invention, a
neurostimulator is provided comprising: an electrical circuit
capable of delivering a train of electrical stimuli that has at
least a train of n number of pulses in one polarity and followed by
a train of at least m number of pulses in the opposite polarity,
where n and m are both equal to 2 or greater whole numbers.
[0019] In some embodiments, n and m are equal whole numbers and the
sum of n pulses is charge-balanced with the sum of m pulses. In
some embodiments n pulses and m pulses have a current amplitude or
voltage amplitude which are substantially different. In some
embodiments n and m are unequal whole numbers and the sum of
charges provided by n pulses is substantially charge-balanced with
the sum of charges provided by m pulses. In some embodiments the
neurostimulator can be shaped and sized for implantation in the
head or neck subcutaneously. In some embodiments, the
neurostimulator can be shaped and sized for implantation in the
chest region or pectoral region of the body.
[0020] In another embodiment, in accordance with the invention, an
implantable neurostimulator comprises: an electrical circuit
capable of delivering, through at least one electrode contact, a
train of electrical stimuli that has at least n number of stimuli,
where n is 3 or a greater whole number, such that each stimulus is
represented by N1, N2, . . . , N-Last in one time window and where
the train of stimuli does not have a fixed frequency.
[0021] In some embodiments, the frequency is not fixed but is
variable as measured between the time duration between N1 and N2
compared to the time duration N2 and N3. In some embodiments, the
duration between adjacent stimuli is entirely randomized with no
fixed frequency, where the total number of stimuli represented by
N1, N2, . . . , N-Last, occurring in a time window can be
selectable through software programming that is resident in the
neurostimulator. In some embodiments, the neurostimulator can be
sized and shaped to be implanted in the head or neck
subcutaneously. In other embodiments, the housing is comprised of a
conductive metal capable of being selected and used as an
indifferent return electrode to operate in a monopolar stimulation
mode.
[0022] In some embodiments, each stimuli N1, N2, . . . , N-Last, is
biphasic, having a peak in both polarity directions and is charge
balanced. In other embodiments, each stimuli NI, N2, . . . ,
N-Last, can be symmetric and charge balanced. In some embodiments,
each stimuli N1, N2, . . . , N-Last, can be biphasic, not
symmetric, and charge balanced.
[0023] In a further embodiment, in accordance with the invention, a
stimulation system comprises: an implantable neurostimulator and at
least one lead connected to the neurostimulator, the lead having
one or more electrode contacts and configured to be implanted in
the brain, where the neurostimulator is capable of providing a
train of stimulation pulses having a frequency from about 20 Hz to
about 50 KHz. The neurostimulator may be shaped and sized to be
implanted subcutaneously in the head.
[0024] In yet a further embodiment, in accordance with the
invention, a deep brain stimulation system comprises: an
implantable neurostimulator; and at least one lead that can be
connected to the neurostimulator, the lead having one or more
electrode contacts and configured to be implanted in the brain,
where the neurostimulator is capable of providing a selectable
stimulus frequency in at least the range from about 100 Hz to about
4.8 KHz. In some embodiments, a neurostimulator can be capable of
providing a selectable stimulus frequency in at least the range
from about 500 Hz to about 4.8 kHz; in at least the range of about
100 Hz to about 4.8 kHz; and in at least the range of about 100 Hz
to about 500 Hz.
BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The above and other aspects, features and advantages of the
present invention will be more apparent from the following more
particular description thereof, presented in conjunction with the
following drawings wherein:
[0026] FIG. 1 shows, in accordance with the present invention, an
illustration of a neurostimulator and lead, where the
neurostimulator is implanted in the back;
[0027] FIG. 2 shows, in accordance with the present invention, an
illustration of a total stimulation system showing the
neurostimulator and lead system that is implanted in the body with
ancillary external devices;
[0028] FIG. 3 shows, in accordance with the present invention, an
illustration of a neurostimulator that can be implanted in the
head; and
[0029] FIGS. 4A-4D show, in accordance with the present invention,
example stimulus shapes and patterns that the neurostimulator
depicted in FIGS. 1,2, and 3 can deliver via the electrode contact
or contacts on the lead.
[0030] Corresponding reference characters indicate corresponding
components throughout the several views of the drawings.
DETAILED DESCRIPTION OF THE INVENTION
[0031] The following description is the best mode for presently
contemplated for carrying out the invention. This description is
not to be taken in a limiting sense, but is made merely for the
purpose of describing the general principles of the invention. The
scope of the invention should be determined with reference to the
claims.
[0032] FIG. 1 shows, in accordance with the present invention, an
embodiment of a stimulation system with a neurostimulator 301
having a connector block 302 with two lead connectors 303 and 304
for connecting two leads 101 and 201, respectively. The leads have
at their distal ends a set of electrode contacts 151 and 251 made
from conductive metal such as a platinum-iridium which are typical
implantable electrode contact materials. An example of a linear or
percutaneous electrode lead is shown in the following: U.S. Pat.
No. 6,510,347. Another choice of leads is the kind having paddle
electrodes 152 and 252 (shown in FIG. 2) at the distal portion of
the leads, the electrodes having one more electrode contacts 500,
501, 502 and 600, 601, and 602, as shown in FIG. 2. An example of a
paddle-type electrode lead is shown in U.S. Pat. No. 7,697,995. The
neurostimulator can be implanted in the upper chest area below the
clavicle, by wrapping the leads 102 and 202 around the neck.
[0033] FIG. 2 shows, in accordance with the present invention, an
embodiment of a stimulation system which includes a neurostimulator
301 with a pair of leads 102 and 202. When the length of leads 102
or 202 is too short and needs to be longer, a lead extension (not
shown) may be used to connect the lead 102 to the neurostimulator
300 and/or lead 202 to the neurostimulator. The stimulation system
can include a diagnostic programmer 803 so that the manufacturer
can communicate via an RF link 704 with the neurostimulator before
and after its implantation for the purpose of testing and gathering
data from the neurostimulator 301.
[0034] The clinician programmer 802 may be used by the clinician or
care-giver to program the neurostimulator 301 with an RF link 703
and also receive patient and device data from the neurostimulator
which may be used for diagnostic purposes. Examples of parameters
which may be programmed are basic stimulus parameters such as
voltage or current amplitudes, stimulus pulsewidths and frequencies
of a train of stimuli. The patient programmer 801 can be a
hand-held programmer that the patient can operate to make limited
programming choices with an RF link 702 to adjust parameters such
as stimulus voltage or current amplitudes and frequencies in order
to fine tune parameter settings.
[0035] An external battery charger 800 may be included in the
stimulation system if the neurostimulator 301 does not use a
primary, one-time-use only battery, but instead the neurostimulator
contains a rechargeable battery that may be recharged
transcutaneously using inductive coupling. The external charger
itself may contain at least a first coil that is used for inductive
coupling with the neurostimulator 301 to transfer power through the
coil in the external charger to a receiving coil inside the
neurostimulator 301. The first coil may be external to the battery
charger housing, connected to the battery charger by a cord. A
separate, second coil may be inside the battery charger housing or
the second coil may be external and also connected by a cord to the
battery charger housing, which second coil is used for
communication with the implanted neurostimulator 301. If the
neurostimulator contains and uses a primary, one-time-use only
battery, the battery charger 800 would not be needed in such a
stimulation system. Communication between the external battery
charger 800 and neurostimulator 301 can occur via an RF link
700.
[0036] FIG. 3 shows, in accordance with the present invention, a
neurostimulator 300 and lead 100, 200 system with electrodes 150,
250, where the neurostimulator 300 is sized and shaped to be
implanted over the surface of the skull and underneath the skin,
i.e., subcutaneously. Such a neurostimulator 300 may have a smaller
housing than a neurostimulator 301, which is sized and shaped to be
implanted in a body area other than the neck and head.
Neurostimulator 300 must necessarily be smaller in volume than
neurostimulator 301 and be shaped so as to not protrude out while
implanted in the head. Because of practical implant limits on the
largest size of the neurostimulator 300 that can be implanted in
the head, if a primary battery is used in the neurostimulator, it
must be relatively small in volume and yet, last for many years.
Using a rechargeable battery in neurostimulator 300 will permit
using a smaller housing and obviate the need to have more frequent
replacements of the neurostimulator which has a primary,
one-time-use only, battery. Neurostimulator 300 may be shaped to
accommodate the surface curvature of the human skull.
[0037] The neurostimulator 300 or 301 is depicted in FIGS. 1, 2,
and 3 as having two lead connectors, connected to two leads, but in
some embodiments in accordance with the present invention, there
will only be a single lead connector, or in other embodiments in
accordance with the invention, three, four or even more lead
connectors may be present in the neurostimulator. In some
embodiments, the neurostimulator 300, 301 can be integrally
connected to one or more leads with no lead connector, i.e., the
leads or leads are permanently connected to the neurostimulator and
cannot be disconnected. In addition, in some embodiments, the
neurostimulator 300 or 301 can have a housing made at least
partially from a conductive metal that can be selectably activated
(programmed on) so that the conductive metal functions as an
indifferent or return electrode to provide a monopolar or unipolar
electrical stimulation circuit via at least one electrode contact
on at least one lead. As used herein, a "monopolar stimulation" or
"unipolar stimulation" uses the neurostimulator housing conductive
metal as one electrode contact, which will be referred to as an
"indifferent electrode" or a "return electrode" and also uses at
least one of the electrode contacts from at least one lead, as part
of the complete stimulation circuit. It is possible to have
monopolar stimulation occur using two or more electrode contacts,
simultaneously, but the housing must also be functioning
simultaneously as the return or indifferent electrode.
[0038] The neurostimulator 300, 301 may also be optionally operated
(programmed to ON in software) in a bipolar mode where the housing
is not part of the stimulation circuit and at least two electrode
contacts in a single stimulation lead or at least two separate
electrode contacts located on a plurality of leads must be used to
provide a complete bipolar stimulation circuit. A "bipolar"
stimulation will be defined herein as having a stimulation circuit
that utilizes at least two electrode contacts, where at any single
point in time or simultaneously, at least one electrode contact in
the circuit is functioning as a cathode and at least one electrode
contact in the circuit is functioning as an anode. Generally, each
electrode contact in the stimulation circuit will function
alternatively, in time, as both an anode and cathode. In fact,
ideally, each electrode contact will generally put out current and
draw in current in the same quantity of charges within some narrow
time window so as to prevent degradation of the electrode contact
over a long period of time. This equality in the quantity of
charges going in and out of a single electrode contact is call
"charge-balancing". If an electrode contact is operating more of
the time as a cathode or more of the time as an anode in a time
window, that charge imbalance will eventually cause the electrode
contact to degrade over time. It is generally desirable to achieve
stimulation charge balancing so that the electrode contact or
contacts will last for many years while implanted the body.
[0039] FIGS. 4A-4D show, in accordance with the present invention,
embodiments of stimulation regimes and stimuli that can be
delivered by the neurostimulators in the present invention.
[0040] FIG. 4A shows, in accordance with the present invention, a
train of stimuli. The drawing shows, by way of example only, three
stimuli in succession in the train, although the train can be any
number of stimuli in succession as desired. For the sake of
clarity, the train of stimuli depicted shows the output current or
voltage amplitude at one electrode contact over time. Each stimulus
has two phases. If the upward direction depicted as peaks P1, P2 or
P3, is assigned as representing cathodic current into the tissue
from the chosen electrode contact, then the downward direction
depicted by peaks P4, P5 and P6 would represent the same electrode
contact functioning as an anode. The areas within the peaks,
representing total charge, depicted as F and G, are the same and
therefore the single stimuli represented by peaks P1 and P4 would
represent a charge-balanced, bi-phasic pulse having symmetry. In
the present invention, the neurostimulator 300, 301, is configured
in one embodiment to be programmable to deliver a full range of
stimulus frequencies of between about 10 Hz to about 40 kHz, in
some predetermined frequency increments. Other embodiments of
neurostimulators will deliver stimulus range of frequencies at
least between about 500 Hz to 4.8 kHz. Still other embodiments of
neurostimulators will at least deliver stimulus frequency ranges
from about 500 Hz to about 2 kHz. The neurostimulator 300, 301 of
the present invention can operate in either monopolar or bipolar
modes, by choice.
[0041] FIG. 4B shows, for the neurostimulator of the present
invention, another possible embodiment of stimulation train of
stimuli. Each stimulus having peaks P1 and P4, is not symmetric
because the amplitudes, whether in volts or current (mA), are not
equal. However, the areas under the curve, H and I, representing
total charges are equal, and so the stimulus is charge balanced. In
the present invention, in one embodiment, the neurostimulator 300,
301, can be configured to be programmable to deliver a full range
of stimulus frequencies of between about 10 Hz to about 40 kHz.
Some other frequency ranges that can be used include coverage of
frequencies at least between about 500 Hz to about 4.8 kHz. Another
frequency range that can be used includes or covers at least from
about 500 Hz to about 2.0 kHz. The neurostimulator can function in
either monopolar or bipolar modes, by choice.
[0042] FIG. 4C shows another possible embodiment of a stimulation
train of stimuli, from an embodiment of the neurostimulator. The
stimulus having peak amplitude (volts or mA) L1 is not biphasic.
Stimuli having peak amplitudes (volts or mA) L2 and L3 are also not
biphasic. However, considered together as a train of stimuli having
amplitudes L1, L2, L3 and L4, L5 and L6, they will be
charge-balanced when viewed from electrical charge exiting and
returning in a single electrode contact over some brief time
window. In some embodiments, the duration of time between adjacent
pulses, e.g, T10 and T11 may be different, so that there is no
fixed frequency. Similarly, T12 and T13 may not be equal and may
also be different from T10 and T11. The times T10, T11, T12, T13
may be different and determined in advance through selected
software programming using the clinician programmer or, in some
cases, the patient programmer. Or the times T10, T11, T12, T13 may
be different because they are randomized but within a certain
programmed maximum time duration between two adjacent pulses. In
this case, the frequency of stimulation is not fixed, but variable.
The neurostimulator can be selected to function in either monopolar
or bipolar stimulation modes.
[0043] FIG. 4D shows more embodiments of a train of stimuli in
accordance with the present invention. Here, a train of stimuli,
represented as N1, N2, N3 and N4 . . . and so on until N Last, can
have equal peak amplitudes. However, the time duration between
adjacent stimuli, T1, T2, T3, T4 . . . T-Last, may all be
different, either programmed in advanced to all be different or
randomly generated, but where T1, T2, T3, T4 . . . T-Last cannot
exceed some predetermined maximum time duration. Each stimulus is
biphasic and charge balanced. There is no true fixed frequency. The
neurostimulator can be selected to operate in either monopolar or
bipolar modes.
[0044] In one embodiment, a stimulation system comprises: an
implantable neurostimulator having a housing that is (a) sized and
shaped to be implanted subcutaneously in the head or neck area and
(b) where the neurostimulator is configured to provide a train of
stimulus pulses having a frequency at least in the range covering
about 20 Hz to 4.8 kHz. The frequency range offered by the
neurostimulator can be a narrower range, for example, from about
100 Hz to about 4.8 kHz in order to have a neurostimulator that is
less challenging to make. Other possible ranges are about 500 Hz to
about 4.8 kHz. For clarity of meaning as used in this disclosure, a
neurostimulator having a programmable frequency range of 250 Hz to
5.0 kHz would meet the frequency range requirement "from 500 Hz to
4.8 kHz" because the latter frequency range which is narrower is
covered entirely by the former frequency range, which is wider. In
other embodiments the neurostimulator may have a stimulus frequency
at least in the range of about 100 Hz to about 4.8 kHz and yet
another embodiment, at least in the range of about 100 Hz to about
500 Hz. All of these embodiments of stimulation frequency ranges,
in accordance with the present invention, will provide a wider
stimulus frequency choice than a conventional spinal cord
neurostimulator that generally uses low stimulation frequencies
such as 35 Hz.
[0045] In all the above embodiments mentioned, the stimulation lead
may be configured to stimulate, among other nerves in the head and
neck, the occipital nerve or its branches or the trigeminal nerve
or its branches. The stimulation leads may have at the distal ends
paddle-type electrode leads, cuff-type electrode leads or
linear-type (percutaneous) electrode leads. Examples of cuff-type
lead electrodes are found in U.S. Pat. Nos. 3,774,618, 3,654,933
and 9,227,053.
[0046] The implantable stimulation system can also include external
(not implanted) system components such as a patient programmer 801
and/or a clinician programmer 802 which can be used to communicate,
program and query the implanted neurostimulator 300, 301.
[0047] In some embodiments, the neurostimulator has a housing that
is sized and shaped to be implanted subcutaneously over the skull.
The shape of the neurostimulator housing should be much flatter and
smaller than a conventional spinal cord neurostimulator. This will
permit the neurostimulator to be implanted over the skull and
beneath the scalp. Generally, in order to keep the neurostimulator
size small enough to implant in the head or neck area, the battery
is preferably a rechargeable battery that can be charged
inductively through the skin. A primary, one-time-use only battery
could be used as battery technology improves over time by
decreasing battery size, while increasing longevity.
[0048] In some embodiments, a neurostimulator is provided
comprising: an electrical circuit capable of delivering a train of
electrical stimuli that has at least a train of n number of pulses
in one polarity and followed by a train of at least m number of
pulses in the opposite polarity, where n and m are both equal to 2
or greater whole numbers. In some embodiments, n and m can be equal
whole numbers and the sum of n pulses can be charge-balanced with
the sum of m pulses. In some embodiments n pulses and m pulses can
have a current amplitude or voltage amplitude which are different.
Or, n and m can be unequal whole numbers and the sum of charges
provided by n pulses can be charge-balanced with the sum of charges
provided by m pulses.
[0049] In some embodiments, an implantable neurostimulator can
comprise: an electrical circuit capable of delivering, through at
least one electrode contact, a train of electrical stimuli that has
at least n number of stimuli, where n is 3 or a greater whole
number, such that each stimulus is represented by N1, N2, . . . ,
N-Last in one time window, and where the train of stimuli does not
have a fixed frequency.
[0050] As shown in FIG. 4D, the frequency may be variable as
measured from the time duration between N1 and N2 compared to the
time duration between N2 and N3. Or, the duration between adjacent
stimuli can be entirely randomized with no fixed frequency, where
the total number of stimuli N1, N2, . . . , N-Last occurring in a
time window can be selected through software programming that is
resident in the neurostimulator using the clinician programmer 802
or the patient programmer 801.
[0051] In some embodiments each stimuli N1, N2, . . . , N-Last can
be biphasic, having both a peak in both polarity directions and
also charge balanced. In some embodiments each stimuli NI, N2, . .
. , N-Last can be symmetric and charge balanced. As shown in FIG.
4D, in some embodiments each stimuli N1, N2, . . . , N-Last can be
biphasic and charged balanced, although not symmetric.
[0052] In a further embodiment, in accordance with the invention, a
stimulation system is provided comprising: an implantable
neurostimulator and at least one lead connected to the
neurostimulator, the lead having one or more electrode contacts and
configured to be implanted in the brain and where the
neurostimulator is capable of providing a train of stimulation
pulses having a frequency from about 20 Hz to about 50 KHz. The
neurostimulator may be shaped and sized to be implanted
subcutaneously in the head.
[0053] In yet a further embodiment, a deep brain stimulation (DBS)
system can comprise: an implantable neurostimulator; and at least
one stimulation lead that can be connected to the neurostimulator
and the lead is implanted into the brain. The neurostimulator is
capable of providing a selectable stimulus frequency in at least
the range from about 100 Hz to about 4.8 KHz. In some embodiments,
a neurostimulator can be capable of providing a selectable stimulus
frequency in at least the range from about 500 Hz to about 4.8 kHz;
in at least the range of about 100 Hz to about 4.8 kHz; and in at
least the range of about 100 Hz to about 500 Hz. In the broadest
range, the neurostimulator can have frequency range from about 20
Hz to about 50 kHz and that would provide the greatest stimulation
options. However, this latter very wide frequency range may be
technically difficult to implement and may be more expensive to
build into a neurostimulator, so it may be advisable from a
practical standpoint to use the suggested narrower ranges as
mentioned, which will still provide a wide enough frequency range,
compared to conventional spinal cord neurostimulators.
[0054] While the invention herein disclosed has been described by
means of specific embodiments and applications thereof, numerous
modifications and variations could be made thereto by those skilled
in the art without departing from the scope of the invention set
forth in the claims.
* * * * *